Stem Cell Manufacturing Market by Product (HSCs, MSCs, iPSCs, ESCs, Instruments, Media, Consumables), Application (Research, Target Identification, Therapy (Autologous, Allogeneic), Cell Banks), End User (Pharma, Hospitals) - Global Forecast to 2023

The global stem cell manufacturing market is projected to reach USD 14.61 Billion by 2023 from USD 10.19 Billion in 2017, at a CAGR of 6.3 % during 2018–2023.

Objectives of the study are:

• To define, describe, and forecast the stem cell manufacturing market on the basis of product, application, end user, and region
• To provide detailed information regarding the major factors influencing the growth of the stem cell manufacturing market (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets with respect to their individual growth trends, prospects, and contributions to the total stem cell manufacturing market
• To analyze the growth opportunities in the market for various stakeholders and provide details of the competitive landscape for market leaders
• To forecast the market in terms of value of individual segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
• To profile key players and comprehensively analyze their market shares and core competencies2
• To track and analyze strategic developments such as product launches; agreements, partnerships, and collaborations; mergers and acquisitions; and research and development activities in the market

This research study involves the extensive usage of secondary sources, directories, and databases (such as, Bloomberg Business, Factiva, and Dun & Bradstreet), in order to identify and collect information useful for this technical, market-oriented, and financial study of the stem cell manufacturing market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.

To know about the assumptions considered for the study, download the pdf brochure

In 2016 Thermo Fisher Scientific (US), Merck Group (Germany), and Becton, Dickinson and Company (US), held the leading position in the global stem cell manufacturing market. In the past three years, these companies adopted new product launches & upgrades; agreements, collaborations & partnerships; mergers & acquisitions; and expansions as their key business strategies to ensure market dominance. Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec GmBH (Germany), Takara Bio Group (Japan), STEMCELL Technologies (Canada), Pharmicell (South Korea), Osiris Therapeutics (US), Anterogen (South Korea), Cellular Dynamics International (US), MEDIPOST (South Korea), Lonza Group (Switzerland), Holostem Terapie Avanzate (Italy), and Pluristem Therapeutics (Israel) were some of the other major players in this market.

Stakeholders

• Stem cell therapy product manufacturing companies
• Stem cell line manufacturing companies
• Healthcare service providers (including hospitals and surgical centers)
• Pharmaceutical product manufacturing companies
• National and regional research boards and organizations
• Research and development (R&D) companies
• Clinical research organizations (CROs)
• Research laboratories and academic institutes
• Market research and consulting firms
• Stem cell associations and organizations
• Stem cell banks and tissue banks
• Government regulatory authorities
• Government payers and private insurance companies

Scope of the Report

This report categorizes the global stem cell manufacturing market into the following segments and subsegments:

Global Stem Cell Manufacturing Market, by Product

• Stem Cell Lines
  • Embryonic Stem Cells (ESCs)
  • Hemopoietic Stem Cells (HSCs)
  • Mesenchymal Stem Cells (MSCs)
  • Multipotent Adult Progenitor Stem Cells
  • Induced Pluripotent Stem Cells (iPSCs)
  • Neural Stem Cells (NSCs) 
• Instruments
  • Bioreactors & Incubators
  • Cell Sorters
  • Other Instruments
• Culture Media
• Consumables

Global Stem cell Manufacturing Market, by Application

• Research Applications
  • Drug Discovery & Development
  • Life Science Research
• Clinical Applications
  • Autologous Stem Cells
  • Allogeneic Stem Cells
• Cell and Tissue Banking Applications

Global Stem Cell Manufacturing Market, by End User

• Hospitals and Surgical Centers
• Pharmaceutical and Biotech Companies
• Cell Banks and Tissue Banks
• Academic Institutes, Research Laboratories, and CROs
• Other End Users

Global Stem Cell Manufacturing Market, by Region

• North America
  • US
• Europe
• Asia Pacific
• Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Portfolio

• Product Portfolio matrix, which gives a detailed comparison of the product portfolios of the top five companies profiled in the report

Geographic Analysis

• Further breakdown of the European stem cell manufacturing market into Germany, France, the UK, and Rest of Europe (RoE)
• Further breakdown of the Asia Pacific stem cell manufacturing market into Japan, China, India, and Rest of Asia Pacific (RoAPAC)

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Geographic Scope
           1.2.3 Years Considered for the Study
    1.3 Currency Used
    1.4 Market Stakeholders

2 Research Methodology (Page No. - 17)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions
    2.5 Research Limitations

3 Executive Summary (Page No. - 26)

4 Premium Insights (Page No. - 30)
    4.1 Stem Cell Manufacturing: Market Overview (2018)
    4.2 Global Stem Cell Manufacturing Market, By Product, 2018
    4.3 Market, By Application and Region (2018)
    4.4 Market, By End User (2018 vs 2023)
    4.5 Geographic Snapshot: Stem Cell Manufacturing Market (2017)

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Growing Public-Private Investments and Funding in Stem Cell-Based Research
                    5.2.1.2 Growing Public Awareness About the Therapeutic Potency of Stem Cell Products
                    5.2.1.3 Development of Advanced Genomic Analysis Techniques for Quality Control During Stem Cell Manufacturing
                    5.2.1.4 Technological Advancements in Stem Cell Manufacturing and Preservation
                    5.2.1.5 Evolving Regulatory Frameworks for Stem Cell Therapeutics in the US and Europe
           5.2.2 Market Restraints
                    5.2.2.1 Significant Operational Costs Associated With Stem Cell Manufacturing and Banking
           5.2.3 Market Opportunities
                    5.2.3.1 Increased Market Focus on Embryonic Stem Cells (ESCS) and Induced Pluripotent Stem Cells (IPSCS)
                    5.2.3.2 Supportive Government Regulations Across Developing Countries
           5.2.4 Market Challenges
                    5.2.4.1 Technical Limitations Associated With Manufacturing Scale-Up
                    5.2.4.2 Socio-Ethical Concerns Related to the Use of Allogenic and Human Embryonic Stem Cells
           5.2.5 Research Pipeline Analysis: Stem Cell-Based Products/Therapies

6 Stem Cell Manufacturing Market, By Product (Page No. - 48)
    6.1 Introduction
    6.2 Stem Cell Lines
           6.2.1 Induced Pluripotent Stem Cells
           6.2.2 Embryonic Stem Cells
           6.2.3 Multipotent Adult Progenitor Stem Cells
           6.2.4 Mesenchymal Stem Cells
           6.2.5 Hematopoietic Stem Cells
           6.2.6 Neural Stem Cells
    6.3 Instruments
           6.3.1 Bioreactors and Incubators
           6.3.2 Cell Sorters
           6.3.3 Other Instruments
    6.4 Culture Media
    6.5 Consumables

7 Stem Cell Manufacturing Market, By Application (Page No. - 62)
    7.1 Introduction
    7.2 Research Applications
           7.2.1 Drug Discovery and Development
           7.2.2 Life Science Research
    7.3 Clinical Applications
           7.3.1 Allogenic Stem Cell Therapy
           7.3.2 Autologous Stem Cell Therapy
    7.4 Cell and Tissue Banking

8 Stem Cell Manufacturing Market, By End User (Page No. - 72)
    8.1 Introduction
    8.2 Pharmaceutical and Biotechnology Companies
    8.3 Hospitals and Surgical Centers
    8.4 Academic Institutes, Research Laboratories, and Cros
    8.5 Cell Banks and Tissue Banks
    8.6 Other End Users

9 Stem Cell Manufacturing Market, By Region (Page No. - 79)
    9.1 Introduction
    9.2 North America
           9.2.1 US
    9.3 Europe
    9.4 Asia Pacific
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 102)
     10.1 Overview
     10.2 Market Ranking (2016)
     10.3 Competitive Scenario
             10.3.1 Product Launches, Upgrades, and Approvals
             10.3.2 Agreements, Partnerships, and Collaborations
             10.3.3 Acquisitions
             10.3.4 Expansions

11 Company Profiles (Page No. - 107)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     11.1 Merck Group
     11.2 Thermo Fisher Scientific
     11.3 Becton, Dickinson and Company (BD)
     11.4 Bio-Rad Laboratories
     11.5 Miltenyi Biotec
     11.6 Pharmicell
     11.7 Takara Bio Group
     11.8 Stemcell Technologies
     11.9 Osiris Therapeutics
     11.10 Anterogen
     11.11 Cellular Dynamics International (Subsidiary of Fujifilm Holdings Corporation)
     11.12 Medipost
     11.13 Lonza Group
     11.14 Holostem Terapie Avanzate
     11.15 Pluristem Therapeutics

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 160)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Introducing RT: Real-Time Market Intelligence
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details

List of Tables (69 Tables)

Table 1 Key Genome-Based Cell Analysis Products Launched During 2014–2017
Table 2 Global Stem Cell Manufacturing Market, By Product, 2016-2023 (USD Million)
Table 3 Global Market for Stem Cell Lines, By Type, 2016-2023 (USD Million)
Table 4 Market for Stem Cell Lines, By Region, 2016-2023 (USD Million)
Table 5 Key Expansion and Differentiation Technologies to Extract Human-Induced Pluripotent Stem Cell Lines
Table 6 Induced Pluripotent Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 7 Embryonic Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 8 Multipotent Adult Progenitor Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 9 Mesenchymal Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 10 Hematopoietic Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 11 Neural Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 12 Global Market for Instruments, By Type, 2016-2023 (USD Million)
Table 13 Market for Instruments, By Region, 2016-2023 (USD Million)
Table 14 Market for Bioreactors & Incubators, By Region, 2016-2023 (USD Million)
Table 15 Market for Cell Sorters, By Region, 2016-2023 (USD Million)
Table 16 Market for Other Instruments, By Region, 2016-2023 (USD Million)
Table 17 Market Fort Culture Media, By Region, 2016-2023 (USD Million)
Table 18 Market for Consumables, By Region, 2016-2023 (USD Million)
Table 19 Stem Cell Manufacturing Market, By Application, 2016–2023 (USD Million)
Table 20 Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 21 Stem Cell Manufacturing Market for Research Applications, By Region, 2016–2023 (USD Million)
Table 22 Market for Drug Discovery and Development, By Region, 2016–2023 (USD Million)
Table 23 Market for Life Science Research, By Region, 2016–2023 (USD Million)
Table 24 Market for Clinical Applications, By Type, 2016–2023 (USD Million)
Table 25 Market for Clinical Applications, By Region, 2016–2023 (USD Million)
Table 26 Market for Allogenic Stem Cell Therapy, By Region, 2016–2023 (USD Million)
Table 27 Market for Autologous Stem Cell Therapy, By Region, 2016–2023 (USD Million)
Table 28 Market for Cell & Tissue Banking, By Region, 2016–2023 (USD Million)
Table 29 Market, By End User, 2016–2023 (USD Million)
Table 30 Market for Pharmaceutical and Biotechnology Companies, By Region, 2016–2023 (USD Million)
Table 31 Market for Hospitals and Surgical Centers, By Region, 2016–2023 (USD Million)
Table 32 Market for Academic Institutes, Research Laboratories, and Cros, By Region, 2016–2023 (USD Million)
Table 33 Market for Cell Banks and Tissue Banks, By Region, 2016–2023 (USD Million)
Table 34 Market for Other End Users, By Region, 2016–2023 (USD Million)
Table 35 Market, By Region, 2016–2023 (USD Million)
Table 36 North America: Market, By Product, 2016–2023 (USD Million)
Table 37 North America: Market for Stem Cell Lines, By Type, 2016–2023 (USD Million)
Table 38 North America: Market for Instruments, By Type, 2016–2023 (USD Million)
Table 39 North America: Market, By Application, 2016–2023 (USD Million)
Table 40 North America: Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 41 North America: Market for Clinical Applications, By Type, 2016–2023 (USD Million)
Table 42 North America: Market, By End User, 2016–2023 (USD Million)
Table 43 US: Market, By Product, 2016–2023 (USD Million)
Table 44 US: Market for Stem Cell Lines, By Type, 2016–2023 (USD Million)
Table 45 Europe: Market, By Product, 2016–2023 (USD Million)
Table 46 Europe: Market for Stem Cell Lines, By Type, 2016–2023 (USD Million)
Table 47 Europe: Market for Instruments, By Type, 2016–2023 (USD Million)
Table 48 Europe: Market, By Application, 2016–2023 (USD Million)
Table 49 Europe: Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 50 Europe: Market for Clinical Applications, By Type, 2016–2023 (USD Million)
Table 51 Europe: Market, By End User, 2016–2023 (USD Million)
Table 52 Asia Pacific: Stem Cell Manufacturing Market, By Product, 2016–2023 (USD Million)
Table 53 Asia Pacific: Market for Stem Cell Lines, By Type, 2016–2023 (USD Million)
Table 54 Asia Pacific: Market for Instruments, By Type, 2016–2023 (USD Million)
Table 55 Asia Pacific: Market, By Application, 2016–2023 (USD Million)
Table 56 Asia Pacific: Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 57 Asia Pacific: Market for Clinical Applications, By Type, 2016–2023 (USD Million)
Table 58 Asia Pacific: Market, By End User, 2016–2023 (USD Million)
Table 59 RoW: Market, By Product, 2016–2023 (USD Million)
Table 60 RoW: Market for Stem Cell Lines, By Type, 2016–2023 (USD Million)
Table 61 RoW: Market for Instruments, By Type, 2016–2023 (USD Million)
Table 62 RoW: Market, By Application, 2016–2023 (USD Million)
Table 63 RoW: Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 64 RoW: Market for Clinical Applications, By Type, 2016–2023 (USD Million)
Table 65 RoW: Market, By End User, 2016–2023 (USD Million)
Table 66 Key Product Launches, Upgrades, and Approvals, 2014–2017
Table 67 Key Agreements, Partnerships, and Collaborations, 2014–2017
Table 68 Key Acquisitions, 2014–2017
Table 69 Key Expansions, 2014–2017

List of Figures (33 Figures)

Figure 1 Global Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Stem Cell Manufacturing Market: Bottom-Up Approach
Figure 4 Market: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Culture Media Segment to Dominate the Global Stem Cell Manufacturing Market During Forecast Period
Figure 7 Research Applications Segment to Dominate the Market During Forecast Period
Figure 8 Cell and Tissue Banks to Be the Fastest-Growing End-User Segment During 2018-2023
Figure 9 Asia Pacific to Grow at the Highest Rate in the Forecast Period
Figure 10 Rising Public-Private Investments and Funding for Stem Cell-Based Research to Drive Market Growth
Figure 11 Culture Media Segment to Dominate the Global Stem Cell Manufacturing Market During the Forecast Period
Figure 12 North America to Dominate the Market, By Application, in 2018
Figure 13 Cell Banks and Tissue Banks to Be Fastest-Growing Segment During the Forecast Period
Figure 14 North America to Dominate the Global Stem Cell Manufacturing Market During the Forecast Period
Figure 15 Stem Cell Manufcaturing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Stem Cell Lines to Be the Fastest-Growing Segment During 2018-2023
Figure 17 Stem Cell Manufacturing Market, By Application, 2018 vs 2023
Figure 18 Market, By End User, 2018 vs 2023
Figure 19 Geographic Snapshot: Asia Pacific to Be the Fastest Growing Region in Stem Cell Manufacturing Market During the Forecast Period
Figure 20 North America: Market Snapshot
Figure 21 Europe: Market Snapshot
Figure 22 Asia Pacific: Market Snapshot
Figure 23 RoW: Market Snapshot
Figure 24 Global Market Ranking Analysis, By Key Players (2016)
Figure 25 Merck Group: Company Snapshot (2016)
Figure 26 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 27 BD: Company Snapshot (2017)
Figure 28 Bio-Rad Laboratories: Company Snapshot (2016)
Figure 29 Takara Bio Group: Company Snapshot (2017)
Figure 30 Fujifilm Holdings Corporation: Company Snapshot (2017)
Figure 31 Medipost: Company Snapshot (2016)
Figure 32 Lonza Group: Company Snapshot (2016)
Figure 33 Pluristem Therapeutics: Company Snapshot (2016)

The global stem cell manufacturing market is projected to reach USD 14.61 Billion by 2023 from USD 10.75 Billion in 2018, at a CAGR of 6.3%. Factors such as growing public-private investments and funding in stem cell-based research, rising public awareness regarding about the therapeutic potency of stem cell products, development of advanced genomic analysis techniques for quality control during stem cell manufacturing, technological advancements in stem cell manufacturing and preservation, and evolving regulatory frameworks for stem cell therapeutics in the US and Europe are driving the growth of the market.

This report broadly segments the stem cell manufacturing market into product, application, end user, and region. On the basis of product, the market is categorized into culture media, consumables, instruments, and stem cell lines. In 2017, the culture media segment accounted for the largest share of the market. The large market share of this segment is attributed the rising stem cell research and increasing demand for stem cell therapies.

Based on application, the market is categorized into three segments, namely, research, clinical, and cell and tissue banking applications. In 2017, cell and tissue banking applications accounted for the largest share of the market. The dominant share of this segment is credited to the increasing public demand for cord blood stem cell banking and rising awareness regarding the prospective advantages of stem cell preservation.

On the basis of end user, the market is segmented into hospitals and surgical centers; pharmaceutical and biotech companies; cell banks and tissue banks; academic institutes, research laboratories, and CROs; and other end users. In 2017, the pharmaceutical and biotech companies accounted for the largest share of the market. The dominant share of this segment is credited to the rising public-private investments for stem cell-based research, ongoing patent expiry of branded drugs, and increasing patient preference for precision & regenerative medicines.

This report covers the market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, North America accounted for the largest share of the market in 2017. The high intensity of stem cell research in the region, rising public-private funding and grants to support the clinical evaluation of stem cells for various applications, robust research infrastructure, and rising public awareness on the therapeutic potency of stem cells are driving the growth of the stem cell manufacturing market in North America. However, the Asia Pacific market is projected to register the highest CAGR during the forecast period. The high growth rate in this region can be attributed to the presence/implementation of supportive regulatory frameworks for stem cell research and manufacturing, ongoing expansion & modernization of healthcare infrastructure across emerging Asian countries, and increasing public-private initiatives to encourage public awareness about stem cell-based treatment.

Factor such as significant operational costs associated with stem cell manufacturing & banking is expected to restrain the growth of the market during the forecast period.

The major players in the market are Thermo Fisher Scientific (US), Merck Group (Germany), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Miltenyi Biotec (Germany), Takara Bio Group (Japan), STEMCELL Technologies (Canada), Pharmicell (South Korea), Osiris Therapeutics (US), Anterogen (South Korea), Cellular Dynamics International (US), MEDIPOST (South Korea), Lonza Group (Switzerland), Holostem Terapie Avanzate (Italy), and Pluristem Therapeutics (Israel), among others.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst